, Volume 3, Issue 10, pp 717–723 | Cite as

Growth responses to patterned GH delivery

  • R. G. Clark
  • D. Mortensen
  • L. M. S. Carlsson
  • D. Carmignac
  • ICAF Robinson


We have investigated the effects of different patterns of administration of recombinant human growth hormone (rhGH) on weight gain, organ growth, serum GH binding protein (GHBP) and insulin-like growth factor-l (IGF-1) levels in a series of studies using hypophysectomized (Hx) or GH-deficient dwarf (dw/dw) rats. Animals were given rhGH either by subcutaneous (s.c.) injections (1 or 2 per day) or s.c. infusions and rhlGF-1 (2 mg/kg/day) by s.c. infusion. In Hx rats, all rhGH regimes increased body weight, tibial epiphyseal plate width, and organ weights in a dose-related manner. Dwarf rats showed a smaller growth response to rhGH than Hx rats, whereas rhGH induced greater elevations in serum GHBP in drarf rats. Growth responses depended on the pattern of rhGH administration (twice daily injections > continuous infusions > daily injections). The shape of the body growth curves also differed; rhGH injections increased weight gain linearly, whereas infusions gave an initial rapid weight gain which slowed with time (a curvilinear response). For both regimens, tibial epiphyseal plate width increased linearly with rhGH dose but infusions were 5-fold more potent than daily injections. Spleen and thymus weights were markedly increased by rhGH and were also affected by the pattern of GH exposure. At 5 mg rhGH/kg/day, thymus weights were 390±35 mg for injectionsvs. 613 ± 34 mg for infusions (P<0.001) compared with 248 ± 16 mg in vehicle-treated Hx controls. Infusions of rhlGF-1 also stimulated specific organ growth but caused less weight gain. RhlGF-1 additively increased the weight gain caused by rhGH injections but not by rhGH infusions. Circulating IGF-1 and GHBP levels were increased in a dose-dependent manner by rhGH infusion, whereas daily injections were ineffective. Thus, differential organ growth could be related to the higher serum IGF-1 concentrations induced by continuous rhGH administration. These studies show that whole body growth is best maintained by intermittent rhGH exposure, whereas, paradoxically, differential organ growth is most pronounced with continuous rhGH administration.


GH IGF-1 infusion injection differential growth 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baumann, G., Shaw, M.A. & Amburn, K. (1989).Metabolism,38, 683–689.PubMedCrossRefGoogle Scholar
  2. Baumbach, W.R., Horner, D.L. & Logan J.S. (1989).Genes Dev.,3, 1199–1205.PubMedCrossRefGoogle Scholar
  3. Baxter, R.C. (1993).Trends Endocrinol. Metab.,4, 91–96.PubMedCrossRefGoogle Scholar
  4. Carmignac, D., Wells, T., Carlsson, L.M.S., Clark, R.G. & Robinson, I.C.A.F. (1992).J. Endocr.,135, 447–457.PubMedGoogle Scholar
  5. Charlton, H.M., Clark, R.G., Robinson, I.C.A.F., Porter-Goff, A.E., Cox, B.S., Bugnon, C. & Bloch, B.S. (1988).J. Endocr.,119, 51–58.PubMedGoogle Scholar
  6. Clark, R.G., Carlsson, L.M.S., Mortensen, D. & Cronin, M.J. (1994).Endocrinology and Metabolism,1, 49–54.Google Scholar
  7. Clark, R.G., Jansson, J.O., Isaksson, O.G.P. & Robinson, I.C.A.F. (1985).J. Endocr.,104, 53–61.PubMedGoogle Scholar
  8. Clark, R., Strasser, J., McCabe, S., Robbins, K. & Jardieu, P. (1993).J. Clin. Invest.,92, 540–548.PubMedCrossRefGoogle Scholar
  9. Cotes, P.M., Bartlett, W.A., Gaines Das, R.E., Flechnell, P. & Termeer, R. (1980).J. Endocr.,87, 303–312.PubMedGoogle Scholar
  10. Daughaday, W.H. (1989).Persp. Biol. Med.,32, 194–211.Google Scholar
  11. Fontoura, M., Mugnier, E., Brauner, R., Rappaport, R. & Postel-Vinay, M.C. (1992).Clin. Endocrinol.,37, 249–253.CrossRefGoogle Scholar
  12. Gargosky, S.E., Tapanainen, P. & Rosenfeld, R.G. (1994).Endocrinology,134, 2267–2276.PubMedCrossRefGoogle Scholar
  13. Gevers, E.F., Wit, J.M. & Robinson, I.C.A.F. (1995).J. Endocr.,145, 69–79.PubMedGoogle Scholar
  14. Groesbeck, M.D. & Parlow, A.F. (1987).Endocrinology,120, 2582–2590.PubMedCrossRefGoogle Scholar
  15. Groesbeck, M.D., Parlow, A.F. & Daughaday, W.H. (1987).Endocrinology,120, 1963–1975.PubMedGoogle Scholar
  16. Guler, H.P., Zapf, J., Scheiwiller, E. & Froesch, E.R. (1988).Proc. Natl. Acad. Sci. USA.,85, 4889–4893.PubMedCrossRefGoogle Scholar
  17. Hazel, S.J., Gillespie, CM., Moore, R.J., Clark, R.G., Jureidini, K.F. & Martin, A.A. (1994).Kidney Int.,46, 58–68.PubMedCrossRefGoogle Scholar
  18. Ho, K.Y., Jorgensen, J., Valiontis, E., Waters, M.J., Rajkovic, I.A. & Christiansen, J.S. (1993).Clin. Endocrinol.,38, 143–148.CrossRefGoogle Scholar
  19. Ho, K.Y. & Kelly, J.J. (1991).Horm. Res.,36, 44–48.PubMedCrossRefGoogle Scholar
  20. Isaksson, O.G.P., Lindahl, A., Nilsson, A. & Isgaard, J. (1987).Endocr. Rev.,8, 426–438.PubMedGoogle Scholar
  21. Isgaard, J., Carlsson, L.M.S., Isaksson, O.G.P. & Jansson, J-O. (1988).Endocrinology,123, 2605–2610.PubMedGoogle Scholar
  22. Jansson, J-O., Albertsson-Wikland, K., Eden, S., Thorngren, K.G. & Isaksson, O.G.P. (1982a).Acta. Endocrinol.,99, 24–30.PubMedGoogle Scholar
  23. Jansson, J-O., Albertsson-Wikland, K., Eden, S., Thorngren, K.G. & Isaksson, O.G.P. (1982b).Acta Physiol. Scand.,114, 261–265.PubMedGoogle Scholar
  24. Jeffery, S., Wilson, C.A., Mode, A., Gustafsson, J-A. & Carter, N.D. (1986).J. Encocr.,110, 123–126.Google Scholar
  25. Klindt, J., Buonomo, F.C. & Yen, J.T. (1992).J. Anim. Sci.,70, 3721–3733.PubMedGoogle Scholar
  26. Maiter, D., Underwood, L.E., Maes, M., Davenport, M.L. & Ketelslegers, J.M. (1988).Endocrinology,123, 1053–1059.PubMedGoogle Scholar
  27. Martha, P.M., Reiter, E.O., Davila, N., Shaw, M.A., Holcombe, J.H. & Baumann G. (1992).J. Clin. Endocrinol. Metab.,75, 1464–1469.PubMedCrossRefGoogle Scholar
  28. Massa, G., Mulumba, N., Ketelslegers, J.M. & Maes, M. (1990).Endocrinology,126, 1976–1980.PubMedGoogle Scholar
  29. Mode, A. (1993).J. Reprod. Fertil.,46, 77–86.Google Scholar
  30. Oscarsson, J., Carlsson, L.M., Bick, T., Lidell, A., Olofsson. S.O. & Eden, S. (1991).J. Endocr.,128, 433–438.PubMedCrossRefGoogle Scholar
  31. Robbins, K., McCabe, S., Scheiner, T., Strasser, J., Clark, R. & Jardieu, P. (1994).Clin. Exp. Immunol.,95, 337–342.PubMedGoogle Scholar
  32. Robinson, I.C.A.F., Carmignac, D.F. & Fairhall, K.M. (1993).Acta Ped.,82, 22–28.CrossRefGoogle Scholar
  33. Robinson, I.C.A.F. & Clark R.G. (1987). In:Growth hormone: Basic and Clinical Aspects. Isaksson, O., Binder, C, Hall, K., Hokfelt, B. (eds). Elsevier: Amsterdam, pp. 109–127.Google Scholar
  34. Schoenle, E., Zapf, J., Humbel, R.E. & Froesch E.R. (1982).Nature,296, 252–253.PubMedCrossRefGoogle Scholar
  35. Skottner, A., Clark, R.G., Fryklund, L. & Robinson, I.C.A.F. (1989).Endocrinology,124, 2519–2526.PubMedGoogle Scholar
  36. Skottner, A., Clark, R.G., Robinson, I.C.A.F. & Fryklund, L. (1987).J. Endocr.,112, 123–132.PubMedGoogle Scholar
  37. Smith, P.J., Hindmarsh, P.C. & Brook, C.G.D. (1988).Arch. Dis. Child.,63, 491–494.PubMedCrossRefGoogle Scholar
  38. Tauber, M., De Bouet Du Portal, H., Sallerin-Caute, B., Rochiccioloi, P. & Bastide, R. (1993).J. Clin. Endocrinol. Metab.,76, 1135–1139.PubMedCrossRefGoogle Scholar
  39. Wise, T., KJindt, J., Buonomo, F.C. & Yen J.T. (1994). In:Growth hormone II: Basic and Clinical Aspects. Bercu, B., Walker, F. (eds). Springer-Verlag: New York. pp. 317–327.Google Scholar

Copyright information

© Humana Press Inc. 1995

Authors and Affiliations

  • R. G. Clark
    • 1
  • D. Mortensen
    • 1
  • L. M. S. Carlsson
    • 2
  • D. Carmignac
    • 3
  • ICAF Robinson
    • 3
  1. 1.Endocrine Research DepartmentGenentech, IncSouth San FranciscoUSA
  2. 2.Research Centre for Endocrinology and MetabolismSahlgren’s HospitalGoteborgSweden
  3. 3.National Institute for Medical ResearchLondonUK

Personalised recommendations